SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-262185
Filing Date
2022-10-13
Accepted
2022-10-13 16:32:06
Documents
12
Period of Report
2022-10-13
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d412455d8k.htm   iXBRL 8-K 28084
  Complete submission text file 0001193125-22-262185.txt   151285

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rna-20221013.xsd EX-101.SCH 2889
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rna-20221013_lab.xml EX-101.LAB 17997
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rna-20221013_pre.xml EX-101.PRE 11285
6 EXTRACTED XBRL INSTANCE DOCUMENT d412455d8k_htm.xml XML 3361
Mailing Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121
Business Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121 858-401-7900
Avidity Biosciences, Inc. (Filer) CIK: 0001599901 (see all company filings)

IRS No.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39321 | Film No.: 221309365
SIC: 2834 Pharmaceutical Preparations